Turmeric

Turmeric (Curcuma longa) is the whole-rhizome source of the curcuminoid family of compounds; the supplement literature heavily overlaps with the curcumin literature because most modern trials standardize the dose to curcuminoid content. Active compounds include curcumin (the most-studied), demethoxycurcumin, bisdemethoxycurcumin, and various volatile oils. The clinical literature spans osteoarthritis (the most-studied indication, which at least one clinical guideline has assessed without recommending for or against), inflammatory and antioxidant biomarkers, lipid profiles, metabolic markers in type 2 diabetes and metabolic syndrome, mood including depression, ulcerative colitis, and many other conditions in smaller research streams.

The outcome dimensions covered most heavily are osteoarthritis (a widely promoted consumer use, with multiple meta-analyses supporting symptomatic benefit), inflammatory and antioxidant biomarkers (the mechanistic basis underlying most claimed benefits), lipid profiles, metabolic markers in type 2 diabetes and metabolic syndrome, mood (depression in particular), and skin and dermatologic conditions. A 2024 synthesis covering 103 RCTs across 42 outcomes (glycemic, lipid, inflammatory, and oxidative markers among them) represents the breadth of the literature better than any single goal-specific meta-analysis.

Demographically, the literature is unusually broad across populations and conditions, a function of curcumin's pleiotropic mechanism. Bioavailability is the central practical question: oral curcumin has very poor absorption, which is why many modern supplemental formulations include absorption enhancers (piperine, phospholipid complexes like Meriva, micellar formulations, or nanoparticle-delivery systems). Form choice meaningfully affects what dose actually reaches systemic circulation, and trial results depend substantially on the formulation used.

Turmeric is generally well-tolerated at typical supplemental doses; NCCIH describes conventional formulations as likely safe for up to 2 or 3 months. The most-common adverse effects are gastrointestinal: nausea, abdominal discomfort, and (at high doses) diarrhea. Turmeric and curcumin supplements are a documented, though rare, cause of drug-induced liver injury, most often with absorption-enhanced formulations but also with plain turmeric; the absolute risk appears low and cases are reported across multiple countries. Drug interactions include theoretical additive effects with anticoagulants (based on platelet-function effects), possible reduced absorption of iron (seen in laboratory work, not confirmed in human trials), and a debated interaction with chemotherapy agents (an ongoing topic in oncology). People with gallstones or liver disease, who are pregnant, on anticoagulants, or undergoing chemotherapy should consult a clinician.

This summary is informational and not medical advice. Consult a clinician before starting or changing any supplement, especially if you take prescription medications.